NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 50 filers reported holding NEOS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,000 | – | 8,605 | +2531.5% | 0.00% | – |
| Q3 2020 | $0 | – | 327 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 327 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 327 | -92.7% | 0.00% | – |
| Q4 2019 | $7,000 | 0.0% | 4,500 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | +133.3% | 4,500 | +125.0% | 0.00% | – |
| Q2 2019 | $3,000 | -92.7% | 2,000 | -87.3% | 0.00% | – |
| Q1 2019 | $41,000 | -62.7% | 15,795 | -76.3% | 0.00% | -100.0% |
| Q4 2018 | $110,000 | -36.4% | 66,724 | +86.7% | 0.00% | 0.0% |
| Q3 2018 | $173,000 | +367.6% | 35,734 | +500.3% | 0.00% | – |
| Q2 2018 | $37,000 | -88.3% | 5,953 | -84.4% | 0.00% | -100.0% |
| Q1 2018 | $316,000 | -53.7% | 38,121 | -43.1% | 0.00% | -40.0% |
| Q4 2017 | $683,000 | +121.8% | 66,980 | +99.2% | 0.01% | +66.7% |
| Q3 2017 | $308,000 | +211.1% | 33,620 | +147.1% | 0.00% | +200.0% |
| Q2 2017 | $99,000 | – | 13,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|